Chemoinformaics analysis of Iriflophenone Tri-O-Galloylglucoside
| Molecular Weight | 712.569 | nRot | 8 |
| Heavy Atom Molecular Weight | 684.345 | nRig | 33 |
| Exact Molecular Weight | 712.128 | nRing | 5 |
| Solubility: LogS | -2.827 | nHRing | 1 |
| Solubility: LogP | 2.191 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 51 | No. of Aromatic Carbocycles | 4 |
| nHetero | 18 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 24 |
| No. of Oxygen atom | 18 | No. of Arom Bond | 24 |
| nHA | 18 | APOL | 88.2162 |
| nHD | 12 | BPOL | 35.9018 |
| QED | 0.069 |
| Synth | 4.568 |
| Natural Product Likeliness | 1.317 |
| NR-PPAR-gamma | 0.85 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.033 |
| Pgp-sub | 0.001 |
| HIA | 0.979 |
| CACO-2 | -6.897 |
| MDCK | 0.0000044 |
| BBB | 0.002 |
| PPB | 0.915586 |
| VDSS | 0.374 |
| FU | 0.0959702 |
| CYP1A2-inh | 0.124 |
| CYP1A2-sub | 0.011 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.023 |
| CYP2c9-inh | 0.504 |
| CYP2c9-sub | 0.055 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.101 |
| CYP3a4-inh | 0.058 |
| CYP3a4-sub | 0.008 |
| CL | 10.057 |
| T12 | 0.942 |
| hERG | 0.072 |
| Ames | 0.209 |
| ROA | 0.004 |
| SkinSen | 0.951 |
| Carcinogencity | 0.029 |
| EI | 0.902 |
| Respiratory | 0.003 |
| NR-Aromatase | 0.766 |
| Antiviral | Yes |
| Prediction | 0.822026 |